Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell

Modern Pathology

Volumn 23, Issue 7, 2010, Pages 1012-1020

  Di Cristofano, Claudio ^a   Leopizzi, Martina ^a   Miraglia, Antonella ^a   Sardella, Barbara ^a   Moretti, Valentina ^a   Ferrara, Alessandro ^a   Petrozza, Vincenzo ^a   Rocca, Carlo Della ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ezrin; osteosarcoma; phosphorylated ezrin Thr567; phosphorylated ezrin Tyr354; subcellular localization; tissue microarray

Indexed keywords

EZRIN; CYTOSKELETON PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SURVIVAL TIME; TISSUE MICROARRAY; BONE TUMOR; CONFOCAL MICROSCOPY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; KAPLAN MEIER METHOD; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; BONE NEOPLASMS; CELL NUCLEUS; CYTOSKELETAL PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MICROSCOPY, CONFOCAL; NEOPLASM METASTASIS; OSTEOSARCOMA; PHOSPHORYLATION; PROTEIN TRANSPORT; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; KAPLAN-MEIER ESTIMATE;

EID: 77954243903     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.77     Document Type: Article

References (32)

1. Campanacci M, editor. Bone and Soft Tissue Tumors ed. Springer-Verlag: Wien-New York, 1999.
2. Ferrari S, Zanella L, Alberghini M, et al. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Pediatr Blood Cancer 2008;50:752-756.
3. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004;10:201-204.
4. Huvos AG, editor. Bone Tumors. Diagnosis, Treatment and Prognosis ed. WB Saunders Company: Philadelphia, 1991.
5. Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol 2007;26:1-18.
6. Folio C, Mora MI, Zalacain M, et al. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets. J Proteome Res 2009;8:3882-3888.
7. Leonard P, Sharp T, Henderson S, et al. Gene expression array profile of human osteosarcoma. Br J Cancer 2003;89:2284-2288.
8. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004;10:182-186.
9. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3:586-599.
10. McClatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 2003;3:877-883.
11. Gautreau A, Poullet P, Louvard D, et al. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999;96:7300-7305.
12. Martin GS. Cell signaling and cancer. Cancer Cell 2003;4:167-174.
13. Bonilha VL, Finnemann SC, Rodriguez-Boulan E. Ezrin promotes morphogenesis of apical microvilli and basal infoldings in retinal pigment epithelium. J Cell Biol 1999;147:1533-1548.
14. Dard N, Louvet-Vallee S, Santa-Maria A, et al. Phosphorylation of ezrin on threonine T567 plays a crucial role during compaction in the mouse early embryo. Dev Biol 2004;271:87-97.
15. Pujuguet P, Del Maestro L, Gautreau A, et al. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 2003;14:2181-2191.
16. Grune T, Reinheckel T, North JA, et al. Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells. FASEB J 2002;16:1602-1610.
17. Zhao H, Shiue H, Palkon S, et al. Ezrin regulates NHE3 translocation and activation after Na+-glucose cotran-sport. Proc Natl Acad Sci USA 2004;101:9485-9490.
18. Tsukita S, Yonemura S. ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction. Curr Opin Cell Biol 1997;9:70-75.
19. Batchelor CL, Woodward AM, Crouch DH. Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. Exp Cell Res 2004;296:208-222.
20. Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004;10:175-181.
21. Wan X, Mendoza A, Khanna C, et al. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res 2005; 65:2406-2411.
22. Curto M, McClatchey AI. Ezriny a metastatic detERMinant? Cancer Cell 2004;5:113-114.
23. Crepaldi T, Gautreau A, Comoglio PM, et al. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J Cell Biol 1997;138:423-434.
24. Zhu L, Zhou R, Mettler S, et al. High turnover of ezrin T567 phosphorylation: conformation, activity, and cellular function. Am J Physiol Cell Physiol 2007;293:C874-C884.
25. Sato N, Funayama N, Nagafuchi A, et al. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci 1992;103(Pt 1):131-143.
26. Sarrio D, Rodríguez-Pinilla SM, Dotor A, et al. Abnormal ezrin localization is associated with clin-icopathological features in invasive breast carcinomas. Breast Cancer Res Treat 2006;98:71-79.
27. Ohtani K, Sakamoto H, Rutherford T, et al. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett 2002;179:79-86.
28. Kaul SC, Kawai R, Nomura H, et al. Identification of a 55-kDa ezrin-related protein that induces cytoskeletal changes and localizes to the nucleolus. Exp Cell Res 1999;250:51-61.
29. Ren L, Hong SH, Cassavaugh J, et al. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 2009;28:792-802.
30. Salas S, de Pinieux G, Gomez-Brouchet A, et al. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma. Virchows Arch 2009;454:81-87.
31. Makitie T, Carpen O, Vaheri A, et al. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 2001;42:2442-2449.
32. Weng WH, Ahlen J, Astrom K, et al. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005;11:6198-6204.